About the Program

The COVAX No-Fault Compensation Program for AMC eligible economies is referred to as the “Program”.

The Program provides no-fault lump sum compensation in full and final settlement of any claims to individuals who have suffered a Serious Adverse Event resulting in permanent impairment or death associated with a COVID-19 Vaccine procured or distributed through the COVAX Facility, or the administration of such a Vaccine, within any AMC Eligible Economy.

The Program is independently administered by ESIS, Inc. (the “Administrator”).

Apply to the Program

Before applying, we suggest that you carefully read:

• the Program Protocol and the Questions & Answers, as they contain important information about the conditions that apply to the Program; and
• the instructions on How to Apply, which provide important information about how to complete and submit your Application materials.

Please note that the Program’s Administrator does not charge any fees for any individual to download, upload or submit an Application Form, or any other Program forms.

Please further note that the Program’s application process will come to an end on 30 June 2027. No Applications will be accepted by the Administrator after 30 June 2027.

Appeal

If your Application has been rejected, or if your Receivable Claim was denied compensation, you have the right to appeal.

Resources

On this website, you will find all the information and resources you need to apply for compensation to the Program. These are available in English, French and Spanish.

 

For your safety, PLEASE read the fraud warning.